Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2014
Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the ratRoberto Ciccocioppo, Serena Stopponi, Daina Economidou, et al.
Neuropharmacology|June 20, 2024
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacyNazzareno Cannella, Veronica Lunerti, Qianwei Shen, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacyVeronica Lunerti, Qianwei Shen, Hongwu Li, et al.
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|March 18, 2003
Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacologyGeorge F Koob, Amanda J Roberts, Brigitte L Kieffer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2016
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug AddictionMarsida Kallupi, Giulia Scuppa, Giordano de Guglielmo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2021
NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring ratsAnna Maria Borruto, Yannick Fotio, Serena Stopponi, et al.
Alcoholism, Clinical and Experimental Research|January 13, 2011
Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the ratDaina Economidou, Andrea Cippitelli, Serena Stopponi, et al.
International Journal of Molecular Sciences|December 10, 2021
Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related DisordersMassimo Ubaldi, Nazzareno Cannella, Anna Maria Borruto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 25, 2018
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principleGustavo Gonzalez-Cuevas, Remi Martin-Fardon, Tony M Kerr, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2010
Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin systemMarsida Kallupi, Nazzareno Cannella, Daina Economidou, et al.
Pageof 8